Gloria Patrick - Verastem Inc | 人才画像

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 11 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

RAMP 205: A Phase 1b/2a Study of Gemcitabine, Nab-Paclitaxel, Avutometinib, and Defactinib in Untreated Metastatic Pancreatic Ductal Adenocarcinoma

Kian-Haut Lim,Manuel Hidalgo,Mark H. O'Hara, Kristen R. Spencer,Ignacio Garrido-Laguna,David G. DeNardo,Vijeta Bhambhani,Gloria Patrick,Yaofeng Cheng,Silvia Coma,Jonathan A. Pachter,Louis J. Denis

CANCER RESEARCHno. 2 (2024)

引用0浏览0引用

Abstract C003: RAMP 205: A Phase 1b/2a Study of Gemcitabine, Nab-Paclitaxel, Avutometinib, and Defactinib in Untreated Metastatic Pancreatic Ductal Adenocarcinoma

Kian-Haut Lim,Manuel Hidalgo,Mark H. O'Hara, Kristen R. Spencer,Ignacio Garrido-Laguna,David G. DeNardo,Vijeta Bhambhani,Gloria Patrick,Yaofeng Cheng,Silvia Coma,Jonathan A. Pachter,Louis J. Denis

Cancer Researchno. 2_Supplement (2024)

引用0浏览0引用

RAMP 202: A Phase 2 Study of Avutometinib (VS-6766) ± Defactinib, in Patients with Advanced KRAS G12V Mutant Non–small Cell Lung Cancer (NSCLC)

Joshua E. Reuss, Sunil G. Gandhi,David R. Spigel,Pasi A. Janne,Luis G. Paz-Ares,Shirish M. Gadgeel,Jyoti D. Patel,Francesco Passiglia,Alexander I. Spira,Martin Joseph Edelman,George R. Blumenschein,Ardaman Shergill,Timothy F. Burns,Vijeta Bhambhani,Gloria Patrick,Jonathan A. Pachter,Louis J. Denis,D. Ross Camidge

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用1浏览0引用

A Phase 2 Study of VS-6766 (RAF/MEK Clamp) RAMP 202, As a Single Agent and in Combination with Defactinib (FAK Inhibitor) in Recurrent KRAS Mutant (mt) and BRAF Mt Non–small Cell Lung Cancer (NSCLC)

D. Ross Camidge,Joshua E. Reuss,Alexander I. Spira,Pasi A. Janne, Muneeb Rehman,Jonathan A. Pachter,Gloria Patrick,Louis J. Denis,David R. Spigel

Journal of Clinical Oncology（2022）

引用0浏览0引用

A Phase 1/2 Study of VS-6766 (RAF/MEK Clamp) in Combination with Sotorasib (G12C Inhibitor) in Patients with KRAS G12C Mutant Non–small Cell Lung Cancer (NSCLC) (RAMP 203)

Ramaswamy Govindan,Mark M. Awad,Shirish M. Gadgeel,Jonathan A. Pachter,Gloria Patrick,Louis J. Denis

Journal of Clinical Oncologyno. 16_suppl (2022): TPS9148-TPS9148

引用1浏览0引用

Abstract CT204: A Phase 1/2 Study of VS-6766 in Combination with Sotorasib in Patients with KRAS G12C Mutant Non-Small Cell Lung Cancer (NSCLC) (RAMP 203)

Ramaswamy Govindan,Jonathan A. Pachter,Andrew G. Koustenis,Gloria Patrick,Louis J. Denis

Cancer Researchno. 12_Supplement (2022): CT204-CT204

引用0浏览0引用

ENGOT-ov60/GOG-3052/RAMP 201: A Phase 2 Study of VS-6766 (RAF/MEK Clamp) Alone and in Combination with Defactinib (FAK Inhibitor) in Recurrent Low-Grade Serous Ovarian Cancer (LGSOC)

Susana Banerjee,Bradley J. Monk,Els Van Nieuwenhuysen,Kathleen N. Moore,Ana Oaknin,Michel Fabbro,Nicoletta Colombo,David M. O’Malley,Robert L. Coleman,Amit M. Oza,Jonathan A. Pachter,Gloria Patrick,Louis J. Denis, Lorna Leonard,Rachel N. Grisham

Journal of Clinical Oncologyno. 16_suppl (2022): TPS5615-TPS5615

引用0浏览0引用

Abstract P048: A phase 2 study of VS-6766 (dual RAF/MEK inhibitor) RAMP 202, as a single agent and in combination with defactinib (FAK inhibitor) in recurrent KRAS-mutant (KRAS-MT) non-small cell lung cancer (NSCLC)

D. Ross Camidge, Jonathan Pachter,Andrew Koustenis,Gloria Patrick,David R. Spigel

Poster Presentations - Proffered Abstracts (2021)

引用0浏览0引用

A phase 2 study of VS-6766 (dual RAF/MEK inhibitor) RAMP 202, as a single agent and in combination with defactinib (FAK inhibitor) in recurrent KRAS-mutant (KRAS-MT) non-small cell lung cancer (NSCLC)

D. Ross Camidge, Jonathan Pachter,Andrew Koustenis,Gloria Patrick,David R. Spigel

MOLECULAR CANCER THERAPEUTICS（2021）

引用0浏览0引用

ENGOT-ov60/GOG3052/RAMP 201: A Phase 2 Study of VS-6766 (dual RAF/MEK Inhibitor) Alone and in Combination with Defactinib (FAK Inhibitor) in Recurrent Low-Grade Serous Ovarian Cancer (LGSOC)

Susana N. Banerjee,Bradley J. Monk,Els Van Nieuwenhuysen,Kathleen N. Moore,Ana Oaknin,Michel Fabbro,Nicoletta Columbo,David M. O'Malley,Robert L. Coleman,Jonathan Pachter,Andrew Koustenis,Gloria Patrick,Lorna Leonard,Rachel Grisham

Molecular Cancer Therapeutics（2021）

引用4浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn